AstraZeneca's expenditure on research and development 2006-2023
This statistic illustrates AstraZeneca's expenditure on research and development from 2006 to 2023. In 2023, AstraZeneca spent some 10.9 billion U.S. dollars on R&D. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Together with the Oxford University, the company also developed one of the first effective COVID-19 vaccines.